{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:14Z","timestamp":1792425494917,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM143127"],"award-info":[{"award-number":["R35GM143127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM067555"],"award-info":[{"award-number":["T32GM067555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007186","name":"UC | UCLA | Jonsson Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000953","name":"Alliance for Cancer Gene Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000953","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-024-01034-7","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:01:49Z","timestamp":1713952909000},"page":"1143-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-9212","authenticated-orcid":false,"given":"Aliya","family":"Lakhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-3143","authenticated-orcid":false,"given":"Mihe","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Khericha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2693-1693","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5583-119X","authenticated-orcid":false,"given":"Yvonne Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-8993","authenticated-orcid":false,"given":"Junyoung O.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"1034_CR1","doi-asserted-by":"publisher","unstructured":"Ho, P. & Chen, Y. Y. Synthetic biology in immunotherapy and stem cell therapy engineering. in Synthetic Biology (eds Smolke, C. et al.) 349\u2013372 (Wiley-VCH, 2018); https:\/\/doi.org\/10.1002\/9783527688104.ch17","DOI":"10.1002\/9783527688104.ch17"},{"key":"1034_CR2","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","volume":"36","author":"JN Brudno","year":"2018","unstructured":"Brudno, J. N. et al. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma. J. Clin. Oncol. 36, 2267\u20132280 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1034_CR3","first-page":"505","volume":"130","author":"AD Cohen","year":"2017","unstructured":"Cohen, A. D. et al. Safety and efficacy of B-cell maturation antigen (BCMA)-specific chimeric antigen receptor T cells (CART-BCMA) with cyclophosphamide conditioning for refractory multiple myeloma (MM). Blood 130, 505 (2017).","journal-title":"Blood"},{"key":"1034_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner, R. G. & Mackall, C. L. Clinical lessons learned from the first leg of the CAR T cell journey. Nat. Med. 25, 1341\u20131355 (2019).","journal-title":"Nat. Med."},{"key":"1034_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147\u2013167 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1034_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger, R. et al. l-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829\u2013842 (2016).","journal-title":"Cell"},{"key":"1034_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41598-019-57026-1","volume":"10","author":"E Can","year":"2020","unstructured":"Can, E. et al. Noninvasive rapid detection of metabolic adaptation in activated human T lymphocytes by hyperpolarized 13C magnetic resonance. Sci. Rep. 10, 200 (2020).","journal-title":"Sci. Rep."},{"key":"1034_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.immuni.2021.02.018","volume":"54","author":"LS Levine","year":"2021","unstructured":"Levine, L. S. et al. Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response. Immunity 54, 829\u2013844 (2021).","journal-title":"Immunity"},{"key":"1034_CR9","doi-asserted-by":"publisher","unstructured":"Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2011.09.021 (2011).","DOI":"10.1016\/j.immuni.2011.09.021"},{"key":"1034_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","volume":"42","author":"J Blagih","year":"2015","unstructured":"Blagih, J. et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42, 41\u201354 (2015).","journal-title":"Immunity"},{"key":"1034_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2016.06.007","volume":"24","author":"N Ron-Harel","year":"2016","unstructured":"Ron-Harel, N. et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 24, 104\u2013117 (2016).","journal-title":"Cell Metab."},{"key":"1034_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s42255-020-0256-z","volume":"2","author":"RI Klein Geltink","year":"2020","unstructured":"Klein Geltink, R. I. et al. Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy. Nat. Metab. 2, 703\u2013716 (2020).","journal-title":"Nat. Metab."},{"key":"1034_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri.2017.99","volume":"18","author":"GR Bantug","year":"2018","unstructured":"Bantug, G. R., Galluzzi, L., Kroemer, G. & Hess, C. The spectrum of T cell metabolism in health and disease. Nat. Rev. Immunol. 18, 19\u201334 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1034_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 21, 1022\u20131033 (2020).","journal-title":"Nat. Immunol."},{"key":"1034_CR15","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","volume":"75","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice. Cancer Res. 75, 3596\u20133607 (2015).","journal-title":"Cancer Res."},{"key":"1034_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-022-01663-0","volume":"21","author":"J Lu","year":"2022","unstructured":"Lu, J. & Jiang, G. The journey of CAR-T therapy in hematological malignancies. Mol. Cancer 21, 194 (2022).","journal-title":"Mol. Cancer"},{"key":"1034_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","volume":"8","author":"RG Majzner","year":"2018","unstructured":"Majzner, R. G. & Mackall, C. L. Tumor antigen escape from CAR T-cell therapy. Cancer Discov. 8, 1219\u20131226 (2018).","journal-title":"Cancer Discov."},{"key":"1034_CR18","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1182\/blood-2019-129600","volume":"134","author":"P Horna","year":"2019","unstructured":"Horna, P., Nowakowski, G., Endell, J. & Boxhammer, R. Comparative assessment of surface CD19 and CD20 expression on B-cell lymphomas from clinical biopsies: implications for targeted therapies. Blood 134, 5345 (2019).","journal-title":"Blood"},{"key":"1034_CR19","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","volume":"119","author":"BG Till","year":"2012","unstructured":"Till, B. G. et al. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood 119, 3940\u20133950 (2012).","journal-title":"Blood"},{"key":"1034_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1158\/2159-8290.CD-22-0964","volume":"13","author":"SM Larson","year":"2023","unstructured":"Larson, S. M. et al. CD19\/CD20 bispecific chimeric antigen receptor (CAR) in naive\/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma. Cancer Discov. 13, 580\u2013597 (2023).","journal-title":"Cancer Discov."},{"key":"1034_CR21","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","volume":"34","author":"G Salles","year":"2017","unstructured":"Salles, G. et al. Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience. Adv. Ther. 34, 2232\u20132273 (2017).","journal-title":"Adv. Ther."},{"key":"1034_CR22","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Rational protein design yields a CD20 CAR with superior antitumor efficacy compared with CD19 CAR. Cancer Immunol. Res. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0504 (2023).","DOI":"10.1158\/2326-6066.CIR-22-0504"},{"key":"1034_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long, A. H. et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med. 21, 581\u2013590 (2015).","journal-title":"Nat. Med."},{"key":"1034_CR24","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1182\/blood-2009-06-225979","volume":"115","author":"E M\u00f6ssner","year":"2010","unstructured":"M\u00f6ssner, E. et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood 115, 4393\u20134402 (2010).","journal-title":"Blood"},{"key":"1034_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1349-7006.2009.01392.x","volume":"101","author":"S Uchiyama","year":"2010","unstructured":"Uchiyama, S. et al. Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope. Cancer Sci. 101, 201\u2013209 (2010).","journal-title":"Cancer Sci."},{"key":"1034_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cels.2018.06.003","volume":"7","author":"LB Tanner","year":"2018","unstructured":"Tanner, L. B. et al. Four key steps control glycolytic flux in mammalian cells. Cell Syst. 7, 49\u201362 (2018).","journal-title":"Cell Syst."},{"key":"1034_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.devcel.2016.02.012","volume":"36","author":"AM Hosios","year":"2016","unstructured":"Hosios, A. M. et al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36, 540\u2013549 (2016).","journal-title":"Dev. Cell"},{"key":"1034_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly, B. & Pearce, E. L. Amino assets: how amino acids support immunity. Cell Metab. 32, 154\u2013175 (2020).","journal-title":"Cell Metab."},{"key":"1034_CR29","doi-asserted-by":"publisher","first-page":"e137761","DOI":"10.1172\/jci.insight.137761","volume":"6","author":"HC Hope","year":"2021","unstructured":"Hope, H. C. et al. Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation. JCI Insight 6, e137761 (2021).","journal-title":"JCI Insight"},{"key":"1034_CR30","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/j.celrep.2019.08.034","volume":"28","author":"N Ron-Harel","year":"2019","unstructured":"Ron-Harel, N. et al. T cell activation depends on extracellular alanine. Cell Rep. 28, 3011\u20133021 (2019).","journal-title":"Cell Rep."},{"key":"1034_CR31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cmet.2022.07.012","volume":"34","author":"I Kaymak","year":"2022","unstructured":"Kaymak, I. et al. Carbon source availability drives nutrient utilization in CD8+ T cells. Cell Metab. 34, 1298\u20131311 (2022).","journal-title":"Cell Metab."},{"key":"1034_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41590-023-01436-x","volume":"24","author":"S Scherer","year":"2023","unstructured":"Scherer, S. et al. Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development. Nat. Immunol. 24, 501\u2013515 (2023).","journal-title":"Nat. Immunol."},{"key":"1034_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2010.10.004","volume":"40","author":"KE Wellen","year":"2010","unstructured":"Wellen, K. E. & Thompson, C. B. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol. Cell 40, 323\u2013332 (2010).","journal-title":"Mol. Cell"},{"key":"1034_CR34","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.201501101","volume":"208","author":"MR Bond","year":"2015","unstructured":"Bond, M. R. & Hanover, J. A. A little sugar goes a long way: the cell biology of O-GlcNAc. J. Cell Biol. 208, 869\u2013880 (2015).","journal-title":"J. Cell Biol."},{"key":"1034_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","volume":"1800","author":"C Butkinaree","year":"2010","unstructured":"Butkinaree, C., Park, K. & Hart, G. W. O-linked \u03b2-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 1800, 96\u2013106 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"1034_CR36","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ni.3439","volume":"17","author":"M Swamy","year":"2016","unstructured":"Swamy, M. et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat. Immunol. 17, 712\u2013720 (2016).","journal-title":"Nat. Immunol."},{"key":"1034_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cmet.2022.11.013","volume":"35","author":"HN Bell","year":"2023","unstructured":"Bell, H. N. et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 35, 134\u2013149 (2023).","journal-title":"Cell Metab."},{"key":"1034_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305","volume":"358","author":"JB Spinelli","year":"2017","unstructured":"Spinelli, J. B. et al. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science 358, 941\u2013946 (2017).","journal-title":"Science"},{"key":"1034_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mrm.21694","volume":"60","author":"M-B Tessem","year":"2008","unstructured":"Tessem, M.-B. et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 60, 510\u2013516 (2008).","journal-title":"Magn. Reson. Med."},{"key":"1034_CR40","doi-asserted-by":"publisher","first-page":"108500","DOI":"10.1016\/j.celrep.2020.108500","volume":"33","author":"WJ Quinn 3rd","year":"2020","unstructured":"Quinn, W. J. 3rd et al. Lactate limits T cell proliferation via the NAD(H) redox state. Cell Rep. 33, 108500 (2020).","journal-title":"Cell Rep."},{"key":"1034_CR41","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293 (2017).","journal-title":"Cell Metab."},{"key":"1034_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41589-019-0364-9","volume":"15","author":"JO Park","year":"2019","unstructured":"Park, J. O. et al. Near-equilibrium glycolysis supports metabolic homeostasis and energy yield. Nat. Chem. Biol. 15, 1001\u20131008 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1034_CR43","doi-asserted-by":"publisher","unstructured":"Fell, D. A. Metabolic control analysis. in Metabolic Engineering: Concepts and Applications Vol. 13b (eds Nielsen, J. et al.) 171\u2013211 (Wiley-VCH, 2021); https:\/\/doi.org\/10.1002\/9783527823468.ch6","DOI":"10.1002\/9783527823468.ch6"},{"key":"1034_CR44","doi-asserted-by":"publisher","first-page":"eaaz3223","DOI":"10.1126\/sciadv.aaz3223","volume":"6","author":"SE Lindner","year":"2020","unstructured":"Lindner, S. E., Johnson, S. M., Brown, C. E. & Wang, L. D. Chimeric antigen receptor signaling: functional consequences and design implications. Sci. Adv. 6, eaaz3223 (2020).","journal-title":"Sci. Adv."},{"key":"1034_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.cgt.7700710","volume":"11","author":"M Moeller","year":"2004","unstructured":"Moeller, M. et al. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells. Cancer Gene Ther. 11, 371\u2013379 (2004).","journal-title":"Cancer Gene Ther."},{"key":"1034_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nchembio.2565","volume":"14","author":"ZL Chang","year":"2018","unstructured":"Chang, Z. L. et al. Rewiring T-cell responses to soluble factors with chimeric antigen receptors. Nat. Chem. Biol. 14, 317\u2013324 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1034_CR47","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.4049\/jimmunol.0900447","volume":"183","author":"Y Zhao","year":"2009","unstructured":"Zhao, Y. et al. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J. Immunol. 183, 5563\u20135574 (2009).","journal-title":"J. Immunol."},{"key":"1034_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","volume":"33","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness. Cell Res. 33, 341\u2013354 (2023).","journal-title":"Cell Res."},{"key":"1034_CR49","doi-asserted-by":"publisher","first-page":"927153","DOI":"10.3389\/fimmu.2022.927153","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Zhu, L., Zhang, H., Chen, S. & Xiao, Y. CAR-T cell therapy in hematological malignancies: current opportunities and challenges. Front. Immunol. 13, 927153 (2022).","journal-title":"Front. Immunol."},{"key":"1034_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000496870","volume":"46","author":"M Subklewe","year":"2019","unstructured":"Subklewe, M., von Bergwelt-Baildon, M. & Humpe, A. Chimeric antigen receptor T cells: a race to revolutionize cancer therapy. Transfus. Med. Hemother. 46, 15\u201324 (2019).","journal-title":"Transfus. Med. Hemother."},{"key":"1034_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44, 380\u2013390 (2016).","journal-title":"Immunity"},{"key":"1034_CR52","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s43018-021-00244-2","volume":"2","author":"K Hirabayashi","year":"2021","unstructured":"Hirabayashi, K. et al. Dual targeting CAR-T cells with optimal costimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors. Nat. Cancer 2, 904\u2013918 (2021).","journal-title":"Nat. Cancer"},{"key":"1034_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","volume":"3","author":"M Hudecek","year":"2015","unstructured":"Hudecek, M. et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol. Res 3, 125\u2013135 (2015).","journal-title":"Cancer Immunol. Res"},{"key":"1034_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature12445","volume":"500","author":"ML Reaves","year":"2013","unstructured":"Reaves, M. L., Young, B. D., Hosios, A. M., Xu, Y.-F. & Rabinowitz, J. D. Pyrimidine homeostasis is accomplished by directed overflow metabolism. Nature 500, 237\u2013241 (2013).","journal-title":"Nature"},{"key":"1034_CR55","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.tcb.2020.02.005","volume":"30","author":"K Kurmi","year":"2020","unstructured":"Kurmi, K. & Haigis, M. C. Nitrogen metabolism in cancer and immunity. Trends Cell Biol. 30, 408\u2013424 (2020).","journal-title":"Trends Cell Biol."},{"key":"1034_CR56","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/intimm\/dxh120","volume":"16","author":"W-J Chae","year":"2004","unstructured":"Chae, W.-J. et al. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor \u03b6 chain ITAMs and their tyrosine residues. Int. Immunol. 16, 1225\u20131236 (2004).","journal-title":"Int. Immunol."},{"key":"1034_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0161-5890(97)00144-2","volume":"34","author":"IC Nicholson","year":"1997","unstructured":"Nicholson, I. C. et al. Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma. Mol. Immunol. 34, 1157\u20131165 (1997).","journal-title":"Mol. Immunol."},{"key":"1034_CR58","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-17-0855","volume":"23","author":"KA Zettlitz","year":"2017","unstructured":"Zettlitz, K. A. et al. ImmunoPET of malignant and normal B cells with 89Zr- and 124I-labeled obinutuzumab antibody fragments reveals differential CD20 internalization in vivo. Clin. Cancer Res. 23, 7242\u20137252 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1034_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/bbmt.1998.v4.pm9763110","volume":"4","author":"M Jensen","year":"1998","unstructured":"Jensen, M., Tan, G., Forman, S., Wu, A. M. & Raubitschek, A. CD20 is a molecular target for scFvFc:\u03b6 receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy. Biol. Blood Marrow Transplant. 4, 75\u201383 (1998).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"1034_CR60","doi-asserted-by":"publisher","first-page":"W276","DOI":"10.1093\/nar\/gkac240","volume":"50","author":"F Madeira","year":"2022","unstructured":"Madeira, F. et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 50, W276\u2013W279 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1034_CR61","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.4049\/jimmunol.0904089","volume":"184","author":"DM Mitchell","year":"2010","unstructured":"Mitchell, D. M., Ravkov, E. V. & Williams, M. A. Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells. J. Immunol. 184, 6719\u20136730 (2010).","journal-title":"J. Immunol."},{"key":"1034_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-016-0329-3","volume":"9","author":"HH Van Acker","year":"2016","unstructured":"Van Acker, H. H. et al. Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells. J. Hematol. Oncol. 9, 101 (2016).","journal-title":"J. Hematol. Oncol."},{"key":"1034_CR63","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nchembio.2077","volume":"12","author":"JO Park","year":"2016","unstructured":"Park, J. O. et al. Metabolite concentrations, fluxes and free energies imply efficient enzyme usage. Nat. Chem. Biol. 12, 482\u2013489 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"1034_CR64","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1021\/acs.analchem.8b03132","volume":"91","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Peak annotation and verification engine for untargeted LC\u2013MS metabolomics. Anal. Chem. 91, 1838\u20131846 (2019).","journal-title":"Anal. Chem."},{"key":"1034_CR65","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/metabo12080684","volume":"12","author":"P Seitzer","year":"2022","unstructured":"Seitzer, P., Bennett, B. & Melamud, E. MAVEN2: an updated open-source mass spectrometry exploration platform. Metabolites 12, 684 (2022).","journal-title":"Metabolites"},{"key":"1034_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ymben.2006.09.001","volume":"9","author":"MR Antoniewicz","year":"2007","unstructured":"Antoniewicz, M. R., Kelleher, J. K. & Stephanopoulos, G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab. Eng. 9, 68\u201386 (2007).","journal-title":"Metab. Eng."},{"key":"1034_CR67","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymben.2006.01.004","volume":"8","author":"MR Antoniewicz","year":"2006","unstructured":"Antoniewicz, M. R., Kelleher, J. K. & Stephanopoulos, G. Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab. Eng. 8, 324\u2013337 (2006).","journal-title":"Metab. Eng."},{"key":"1034_CR68","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"1034_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","journal-title":"EMBnet J."},{"key":"1034_CR70","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"1034_CR71","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1034_CR72","doi-asserted-by":"publisher","first-page":"D603","DOI":"10.1093\/nar\/gkab1106","volume":"50","author":"ME Beber","year":"2022","unstructured":"Beber, M. E. et al. eQuilibrator 3.0: a database solution for thermodynamic constant estimation. Nucleic Acids Res. 50, D603\u2013D609 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1034_CR73","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1034_CR74","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41598-018-36950-8","volume":"9","author":"M Hebditch","year":"2019","unstructured":"Hebditch, M. & Warwicker, J. Web-based display of protein surface and pH-dependent properties for assessing the developability of biotherapeutics. Sci. Rep. 9, 1969 (2019).","journal-title":"Sci. Rep."},{"key":"1034_CR75","doi-asserted-by":"publisher","first-page":"W568","DOI":"10.1093\/nar\/gkw454","volume":"44","author":"I Paz","year":"2016","unstructured":"Paz, I., Kligun, E., Bengad, B. & Mandel-Gutfreund, Y. BindUP: a web server for non-homology-based prediction of DNA and RNA binding proteins. Nucleic Acids Res. 44, W568\u2013W574 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01034-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01034-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01034-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T23:04:39Z","timestamp":1719356679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-024-01034-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1038\/s42255-024-01034-7","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.C. and Y.Y.C. are inventors of a patent whose value may be affected by the publication of this work. Y.Y.C. holds several patent applications in CAR-T cell therapy. Y.Y.C. is a founder of, holds equity in and receives consulting fees from ImmPACT Bio. Y.Y.C. is a member of the scientific advisory board of and holds equity in Catamaran Bio, Notch Therapeutics, Pluto Immunotherapeutics, Prime Medicine, Sonoma Biotherapeutics and Waypoint Bio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}